Cargando…
Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis
BACKGROUND: The optimal treatment of chemotherapy-induced oral mucositis is not well established. A recent study showed that hangeshashinto (TJ-14) might be useful for periodontal disease via downregulating pro-inflammatory prostaglandins in the cyclooxygenase pathway in human. Our study aimed to de...
Autores principales: | Kono, Toru, Satomi, Machiko, Chisato, Naoyuki, Ebisawa, Yoshiaki, Suno, Manabu, Asama, Toshiyuki, Karasaki, Hidenori, Matsubara, Kazuo, Furukawa, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649748/ https://www.ncbi.nlm.nih.gov/pubmed/29147213 http://dx.doi.org/10.4021/wjon263w |
Ejemplares similares
-
Effects of Topical Hangeshashinto (TJ-14) on Chemotherapy-Induced Oral Mucositis
por: Ozawa, Natsuo, et al.
Publicado: (2020) -
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
por: Aoyama, Toru, et al.
Publicado: (2014) -
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
por: Matsuda, Chu, et al.
Publicado: (2015) -
Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation
por: Kono, Toru, et al.
Publicado: (2012) -
The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2018)